Direct Oral Anticoagulants (DOACs) Vs. Low Molecular Weight Heparins (LMWH) for Venous Thromboembolism (VTE) in Patients with Primary Brain Tumors or Secondary Brain Metastases

被引：1
|
作者：
Lee, Angela
Oley, Frank, Jr.
Lo, Mimi
Fong, Richard
McGann, Mary
Saunders, Ila
Block, Shanna
Mahajan, Anjlee
Pon, Tiffany
机构：
来源：
BLOOD | 2020年 / 136卷
关键词：
D O I：
10.1182/blood-2020-138635
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Direct oral anticoagulants or low-molecular-weight heparins for venous thromboembolism in patients with brain tumors
    Lee, Angela
    Oley, Frank, Jr.
    Lo, Mimi
    Fong, Richard
    McGann, Mary
    Saunders, Ila
    Block, Shanna
    Mahajan, Anjlee
    Pon, Tiffany K.
    THROMBOSIS RESEARCH, 2021, 208 : 148 - 155
  • [2] SAFETY OF DIRECT ORAL ANTICOAGULANTS AS COMPARED TO LOW MOLECULAR WEIGHT HEPARIN IN TREATING VENOUS THROMBOEMBOLISM IN PATIENTS WITH PRIMARY BRAIN TUMORS AND BRAIN METASTASES
    Ali, Assad
    Shah, Nirja
    Santiago, Raphael Bastianon
    Mandel, Mauricio
    Obrzut, Michal
    Borghei-Razavi, Hamid
    Adada, Badih
    Ranjan, Surabhi
    NEURO-ONCOLOGY, 2022, 24 : 147 - 147
  • [3] Efficacy and safety of direct oral anticoagulants (DOACs) and low molecular weight heparin (LMWH) for primary prevention of venous thromboembolism (VTE) in ambulatory cancer patients.
    Shenouda, Mina
    Desai, Ruchi
    Jaglal, Michael Vishal
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [4] Safety of Direct Oral Anticoagulants as Compared to Low Molecular Weight Heparin in Treating Venous Thromboembolism in Patients with Primary Brain Tumors and Brain Metastases - A Review of Literature and Meta-analysis
    Santiago, Raphael Bastianon
    Shah, Nirja
    Ali, Asad
    Ranjan, Surabhi
    NEUROLOGY, 2023, 100 (17)
  • [5] EFFECTIVENESS AND SAFETY OF LOW-MOLECULAR-WEIGHT HEPARINS (LMWH) IN THE PREVENTION OF VENOUS THROMBOEMBOLISM (VTE)
    KAKKAR, VV
    THROMBOSIS AND HAEMOSTASIS, 1995, 74 (01) : 364 - 368
  • [6] Tolerability of Direct Oral Anticoagulants and Low Molecular Weight Heparin in Patients with Brain Tumors or CNS Metastases
    Abdelmessih, Emily
    Wo, Stephanie
    Green, David L.
    Leiva, Orly
    Xiang, Elaine
    Ahuja, Tania
    BLOOD, 2023, 142
  • [7] COST-EFFECTIVENESS OF DIRECT ORAL ANTICOAGULANTS (DOACS) VERSUS LOW-MOLECULARWEIGHT HEPARINS (LMWH) IN PATIENTS WITH CANCERASSOCIATED VENOUS THROMBOEMBOLISM (CAT) IN HONG KONG
    Kang, W.
    Peng, K.
    Yan, V
    Chan, E. W.
    VALUE IN HEALTH, 2023, 26 (12) : S152 - S152
  • [8] Evaluation of direct oral anticoagulants versus low molecular weight heparins for venous thromboembolism treatment in patients with gastrointestinal malignancies
    Guan, Tiffany
    Laguna, Arianna
    Soares, Alisha
    Legasto, Carlo S.
    Block, Shanna
    Saunders, Ila M.
    Alvarez, Kathryn
    Pon, Tiffany
    Patel, Nimish
    Mahajan, Anjlee
    Lee, Angela
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2023, 56 (03) : 439 - 446
  • [9] Evaluation of direct oral anticoagulants versus low molecular weight heparins for venous thromboembolism treatment in patients with gastrointestinal malignancies
    Tiffany Guan
    Arianna Laguna
    Alisha Soares
    Carlo S. Legasto
    Shanna Block
    Ila M. Saunders
    Kathryn Alvarez
    Tiffany Pon
    Nimish Patel
    Anjlee Mahajan
    Angela Lee
    Journal of Thrombosis and Thrombolysis, 2023, 56 : 439 - 446
  • [10] LOW-MOLECULAR-WEIGHT HEPARINS (LMWH) IN THE TREATMENT OF PATIENTS WITH ACUTE VENOUS THROMBOEMBOLISM
    HIRSH, J
    SIRAGUSA, S
    COSMI, B
    GINSBERG, JS
    THROMBOSIS AND HAEMOSTASIS, 1995, 74 (01) : 360 - 363
12345